Sanofi India · NSE: SANOFI · BSE: 500674
Q1 FY22 results · Apr–Jun 2021
Sanofi India reported revenue from operations of ₹789.10 crore (up 11.1% from Q1 FY21) and net profit of ₹178.30 crore (up 30.8% from Q1 FY21) for Q1 FY22 (Apr–Jun 2021), on a standalone basis.
| Item | Q1 FY22 | Q1 FY21 | YoY | Q4 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 789.10 | 710.50 | +11.1% | 725.10 | +8.8% |
| Other income | 17.10 | 29.20 | −41.4% | 26.30 | −35.0% |
| Total income | 806.20 | 739.70 | +9.0% | 751.40 | +7.3% |
| Profit before tax | 242.60 | 186.50 | +30.1% | 194.90 | +24.5% |
| Net profit for the period | 178.30 | 136.30 | +30.8% | 145.90 | +22.2% |
| EPS, basic (₹) | 77.42 | 59.18 | +30.8% | 63.35 | +22.2% |
| Net margin (%) | 22.6 | 19.2 | 20.1 |
Standalone
- Filed with BSE
- 28 Jul 2021, 10:56 IST
- Board meeting
- 27 Jul 2021
- Period
- 01 Apr 2021 to 30 Jun 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE